Dismal outcome of relapsed or primary refractory adult T‐cell lymphoblastic lymphoma: A retrospective study from China

Author:

Chen Haizhu1,Qin Yan1,Yang Jianliang1,Liu Peng1,He Xiaohui1,Zhou Shengyu1,Zhang Changgong1,Yang Sheng1,Gui Lin1,Sun Yan1,Shi Yuankai1ORCID

Affiliation:

1. Department of Medical Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs Beijing China

Publisher

Wiley

Subject

Oncology,General Medicine

Reference28 articles.

1. Adult lymphoblastic lymphoma;Portell CA;Cancer J,2012

2. Treatment of lymphoblastic lymphoma in adults;Sweetenham JW;Oncology (Williston Park),2009

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber DA;Blood,2016

4. Adult B‐ and T‐lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes—A short report from two Sydney centres;Blennerhassett R;Br J Haematol,2020

5. Successful outcomes of newly diagnosed T lymphoblastic lymphoma: Results from Children's Oncology Group AALL0434;Hayashi RJ;J Clin Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3